أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - telmisartan, quantity: 80 mg - tablet, uncoated - excipient ingredients: povidone; magnesium stearate; sorbitol; meglumine; sodium hydroxide - the proposed indications are identical to those for the approved innovator product; based on the latest published micardis pi (most recent amendment jan11) the indications are (i) treatment of hypertension, and (ii) prevention of cardiovascular morbidity and mortality in patients 55 years or older with coronary artery disease, peripheral artery disease, previous stroke, transient ischaemic attack or high risk diabetes with evidence of end organ damage.

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

boehringer ingelheim pty ltd - telmisartan, quantity: 80 mg; hydrochlorothiazide, quantity: 25 mg - tablet, multilayer - excipient ingredients: maize starch; sorbitol; sodium hydroxide; iron oxide yellow; magnesium stearate; lactose monohydrate; microcrystalline cellulose; povidone; sodium starch glycollate type a; meglumine - micardis plus is indicated for the treatment of hypertension. treatment should not be intitiated with these combinations.

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - telmisartan, quantity: 80 mg - tablet, uncoated - excipient ingredients: mannitol; meglumine; povidone; potassium hydroxide; magnesium stearate - treatment of hypertension. prevention of cardiovascular morbidity and mortality in patients 55 years or older with coronary artery disease, peripheral artery disease, previous stroke, transient ischaemic attack or high risk diabetes with evidence of end organ damage.

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - telmisartan, quantity: 80 mg - tablet - excipient ingredients: povidone; sodium hydroxide; magnesium stearate; meglumine; mannitol - telmisartan is indicated for: treatment of hypertension. prevention of cardiovascular morbidity and mortality in patients 55 years or older with coronary artery disease, peripheral artery disease, previous stroke, transient ischaemic attack or high risk diabetes with evidence of end organ damage (see clinical trials).

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - telmisartan, quantity: 80 mg - tablet - excipient ingredients: meglumine; magnesium stearate; sodium hydroxide; povidone; mannitol - telmisartan is indicated for: treatment of hypertension. prevention of cardiovascular morbidity and mortality in patients 55 years or older with coronary artery disease, peripheral artery disease, previous stroke, transient ischaemic attack or high risk diabetes with evidence of end organ damage (see clinical trials).

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - telmisartan, quantity: 80 mg - tablet - excipient ingredients: meglumine; mannitol; magnesium stearate; sodium hydroxide; povidone - telmisartan is indicated for: treatment of hypertension. prevention of cardiovascular morbidity and mortality in patients 55 years or older with coronary artery disease, peripheral artery disease, previous stroke, transient ischaemic attack or high risk diabetes with evidence of end organ damage (see clinical trials).

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - telmisartan, quantity: 80 mg - tablet - excipient ingredients: povidone; mannitol; magnesium stearate; meglumine; sodium hydroxide - telmisartan is indicated for: treatment of hypertension. prevention of cardiovascular morbidity and mortality in patients 55 years or older with coronary artery disease, peripheral artery disease, previous stroke, transient ischaemic attack or high risk diabetes with evidence of end organ damage (see clinical trials).

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - telmisartan, quantity: 40 mg - tablet - excipient ingredients: sodium stearylfumarate; povidone; magnesium stearate; meglumine; mannitol; sodium hydroxide - teltartan is indicated for:,treatment of hypertension,prevention of cardiovascular morbidity and mortality in patients 55 years or older with coronary artery disease, peripheral artery disease, previous stroke, transient ischaemic attack or high risk diabetes with evidence of end organ damage (see clinical trials)

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - amlodipine besilate, quantity: 6.935 mg (equivalent: amlodipine, qty 5 mg); telmisartan, quantity: 40 mg - tablet, film coated - excipient ingredients: titanium dioxide; sodium hydroxide; magnesium stearate; mannitol; meglumine; hypromellose; povidone; propylene glycol; purified water; isopropyl alcohol; iron oxide black - treatment of hypertension. treatment should not be initiated with this fixed-dose combination. (see dosage and administration)

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - amlodipine besilate, quantity: 13.87 mg (equivalent: amlodipine, qty 10 mg); telmisartan, quantity: 40 mg - tablet, film coated - excipient ingredients: titanium dioxide; sodium hydroxide; meglumine; mannitol; hypromellose; povidone; magnesium stearate; propylene glycol; purified water; isopropyl alcohol; iron oxide black - treatment of hypertension. treatment should not be initiated with this fixed-dose combination. (see dosage and administration)